Alexion Pharmaceuticals Stock Forecast, ALXN stock price prediction. Share Price & News How has Alexion Pharmaceuticals's share price performed over time and what events caused price changes? Elliott did not immediately respond to a request for comment. Astra buys Alexion for a share price of $175 Reply 1 0 Report Juice Leskinen Dec 14, 2020 5:20AM ET Share Follow this post Unfollow this post Save Saved. Elliott first invested in Alexion in 2017 when the share price was only slightly lower than Friday's close of $120.98. adjusted to account for any stock splits and/or dividends which may have A popular way to gauge a stock's volatility is its "beta". $150.15. The cash and stock deal, the largest in AstraZeneca’s AZN, -0.93% history, values Alexion ALXN, -0.59% at $175 per share and has been agreed upon by the boards of directors of both companies. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. Comparatively, Alexion Pharmaceuticals has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500. $148.19. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been Real time Alexion Pharmaceuticals (ALXN) stock price quote, stock graph, news & analysis. DJIA. The average Alexion Pharmaceuticals stock price for the last 52 weeks is 119.35 . Alexion started the day with a market cap of around $26.5 billion with approximately 218.8 million shares outstanding and a short interest of about 1.9%. This website is intended only for residents of the United States. To enable Verizon Media and our partners to process your personal data select 'I agree', or select 'Manage settings' for more information and to manage your choices. The closing price above is not necessarily indicative of future price Over the last year, Alexion Pharmac share price has been traded in a range of 81.53464, hitting a high of 161.65318, and a low of 80.11854. Over the last 12 months, Alexion Pharmaceuticals's shares have ranged in value from as little as $72.67 up to $162.6. Alexion Pharmaceuticals Inc A Boston pharmaceutical company, Alexion Pharmaceuticals Inc. focuses primarily on immune system research and rare blood disorders. Find real-time ALXN - Alexion Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. AstraZeneca is offering $60 in cash plus 2.1243 shares of stock for every Alexion share, representing a total package worth $175 per share based on AstraZeneca's closing stock price on … AstraZeneca’s share price has now fallen by more than 20% from the 52-week high of 10,120p seen earlier this year. Alexion Pharmaceuticals Stock Forecast, AXP stock price prediction. [1] The agreed price represents a 45% premium over Alexion’s share price, and will be AstraZeneca’s largest acquisition to date, assuming it receives regulatory and shareholder’s approval. ALXN:NASDAQ GS Stock Quote - Alexion Pharmaceuticals Inc - Bloomberg Markets. This represents a 45% premium to Alexion's closing share price … What appears to be exercising some who follow AstraZeneca is the price it is paying. The stock is down by more than 5% after the company revealed that it would acquire Alexion in a $39 billion deal. Find the latest Alexion Pharmaceuticals, Inc. (ALXN) stock quote, history, news and other vital information to help you with your stock trading and investing. View live ALEXION PHARMACEUTICAL INC chart to track its stock's price action. Astra buys Alexion for a share price of $175 Reply 1 0 Report Juice Leskinen Dec 14, 2020 5:20AM ET Share Follow this post Unfollow this post Save Saved. NASDAQ. But profits are on track to rise … Alexion is widely known for developing the drug Soliris, a treatment for paroxysmal nocturnal haemoglobinuria that received FDA approval in … cumulative factor which encapsulates all splits since the date shown above. Historical daily share price chart and data for Alexion Pharmaceuticals since 1996 adjusted for splits. View real-time stock prices and stock quotes for a full financial overview. Bloomberg reports, "the offer values Alexion at $175 a share, a 45% premium to the closing price on Friday". The latest closing stock price for Alexion Pharmaceuticals as of March 05, 2021 is 150.10.. Even after Ultomiris’ launch in late 2018, the company’s stock price has stayed pretty much flat. See Saved Items. Find market predictions, ALXN financials and market news. Alexion shareholders will be paid $60 USD per share in cash, as well as 2.1243 AstraZeneca American Depositary Shares (ADSs), amounting to a total consideration of $175 USD per share. Elliott first invested in Alexion in 2017 when the share price was only slightly lower than Friday’s close of $120.98. Latest Alexion Pharmaceuticals Inc (ALXN:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. The latest Alexion Pharmaceuticals Inc Contingent Value Rights share price. A popular way to gauge a stock's volatility is its "beta". occurred for this security since the date shown above. Based on AstraZeneca's reference average ADR price of $54.14, this implies total consideration to Alexion shareholders of $39bn or $175 per share. Latest Stock Picks Investing Basics Premium Services … Alexion Pharmaceuticals Inc (ALXN) USD0.0001 Sell: $153.48 Buy: $153.52 Change: $0.87 (0.57%) NASDAQ : 0.04% AstraZeneca has agreed to buy Alexion Pharmaceuticals in a mixed cash and shares deal worth $39bn. At its peak, Alexion’s stock price exceeded $200 a share and commanded a high growth stock P/E ratio of close to 40, which up till then was justified and supported by its operating growth. This is in sharp contrast to its trading at approximately 11 times book value in 2013 and 2014, which is referenced … AstraZeneca shares fell as much as 9% on Monday, as investors moved to price in the costs of a $39 billion deal for U.S. biotech company Alexion Pharmaceuticals that would be … Alexion Pharmaceuticals, Inc. Common Stock. Alexion Pharmaceuticals Inc,ALXN,ISIN: US0153511094 - view the latest price,charts and performance information at AJ Bell Youinvest Skip to main content Alexion Pharmaceuticals Inc (NASDAQ:ALXN) - Share price We use cookies to give you the best online experience. Earnings for Alexion Pharmaceuticals are expected to grow by 5.30% in the coming year, from $11.14 to $11.73 per share. Alexion Pharmaceuticals share price volatility. Free Cash Flow per Share: 11.69 - - - - Book Value per Share: 66.06 77.56 90.86 - - Net Debt-1,886 -2,777 -8,878 The stock is down by more than 5% after the company revealed that it would acquire Alexion in a $39 billion deal. The Split Adjustment Factor is a The stock is down by more than 5% after the company revealed that it would acquire Alexion in a $39 billion deal. $146.97. ALXN.US volatility (beta: 1.34) Avg. Data Provided by Refinitiv. This represents a 45% premium to Alexion's closing share price … Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders. Comparatively, Alexion Pharmaceuticals has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500. Insider & Institutional Ownership. Alexion Pharmaceuticals share price volatility. View recent trades and share price information for Alexion Pharmaceuticals Inc Contingent Value Rights … Alexion closed at $120.97 Wednesday, a 3.4% decrease from the same date three years ago. volatility (beta: 1.00) Low High. Over the last 12 months, Alexion Pharmaceuticals's shares have ranged in value from as little as $72.67 up to $162.6. Price to Earnings Ratio vs. the Market The P/E ratio of Alexion Pharmaceuticals is 35.39, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 32.38. Find real-time ALXN - Alexion Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. See Saved Items. Alexion Pharmaceuticals【ALXN】の株価情報。リアルタイムチャートやニュース、株式掲示板をご覧いただけます。個人投資家のための金融情報サイト-ADVFN 時価総額 発行済株式数 Float 歳入 利益/損失 一株当たり利益 PER US$ 32.98B According to its third quarter financial update, Alexion’s revenue and GAAP earnings per share both popped 26%, to about $1.6 billion and $2.62, respectively, from the previous year. FTSE 100. © 2021 Alexion Pharmaceuticals, Inc. $150.71. +0.61 (+0.41%) ALXN: Get the latest Alexion Pharmaceuticals stock price and detailed information including ALXN news, historical charts and realtime prices. The offer values Alexion at $175 a share, a 45% premium to the closing price on Friday. Access detailed information about the Alexion Pharmaceuticals Inc (ALXN) Share including Price, Charts, Technical Analysis, Historical data, Alexion Reports and more. ALXN shares opened 30% higher today at $157.35 (+$36.37, +30.06%) over Friday's $120.98 closing price and reached a new 52-week high price this morning of $160.03. Alexion's investors will receive £45 cash and 2.1 Astra shares for each Alexion share – or £132 per share, a 45 per cent premium – handing them 15 per cent of the combined company. At the current AstraZeneca share price is the worst-performer in the FTSE 100 today. Based on AstraZeneca's reference average ADR price of $54.14, this implies total consideration to Alexion shareholders of $39bn or $175 per share. Intraday Alexion Pharmac Share Chart. 3,943.34. performance. 13,319.86. Yahoo is part of Verizon Media. One way of making that assessment is to exami... Why Alexion Pharmaceuticals Inc could appeal to contrarian val... 28th May '20 - Ben Hobson View daily, weekly or monthly … Discover historical prices for ALXN stock on Yahoo Finance. Palatin (PTN) Jumps: Stock Rises 8.7% Palatin (PTN) saw a big move last The boards of directors of both companies have unanimously approved the acquisition. An invaluable buyout factsheet for traders and investors looking to trade the merger arbitrage spread . Discover historical prices for ALXN stock on Yahoo Finance. Alexion Pharmaceuticals: Price-To-Book Value Suggest Undervaluation Alexion ended 2019 with the stock price trading at 2.12 times book value. (ALXN) Nasdaq Listed. The Alexion Pharmaceuticals 52-week low stock price is 72.67, which is 51.6% below the current share price. Each ADS represents one … Find out more about how we use your information in our Privacy Policy and Cookie Policy. Elliott did not immediately respond to a request for comment. The offer represents a 45% premium to Alexion's share price … AstraZeneca’s surprise $39billion takeover bid for US biotech firm Alexion wiped 9.2% from its share price early today as investors struggled to identify benefits from the mammoth deal. Based on AstraZeneca's reference average ADR price of $54.14, this implies total consideration to Alexion shareholders of $39bn or $175 per share. volatility (beta: 1.00) Low High. Long-Term Price Volatility Vs. Market How volatile is Alexion Pharmaceuticals's share price compared to the market and industry in the last 5 years? We and our partners will store and/or access information on your device through the use of cookies and similar technologies, to display personalised ads and content, for ad and content measurement, audience insights and product development. This move was aimed to diversify Alexion's hematology, neurology, and critical care commercial portfolio with Portola's Factor Xa inhibitor reversal agent. Financing To support the financing of the offer consideration, AstraZeneca has entered into a new committed $17.5bn bridge-financing facility, provided by Morgan Stanley, J.P. Morgan Securities plc and Goldman Sachs. S&P 500. Moreover, Alexion’s adjusted operating earnings have grown from $0.20 per share in 2008 to $10.53 by 2019, representing an outstanding 43.72% compound annualized growth … Minimum 15 minutes delayed. Earnings & Valuation This table compares Biogen and Alexion Pharmaceuticals' revenue, earnings per share (EPS) and valuation. By using our website, you agree to our use of cookies in accordance with our. AstraZeneca will pay around $175 per share for Alexion, through a combination of cash and shares, representing a near 45% premium to the group's Friday closing price and valuing the … What appears to be exercising some who follow AstraZeneca is the price it is paying. AstraZeneca share price is the worst-performer in the FTSE 100 today. Share Price vs. Fair Value Below Fair Value : ALXN ($153.48) is trading below our estimate of fair value ($300.83) Significantly Below Fair Value : ALXN is trading below fair value by more than 20%. 32,778.64. The all-time high Alexion Pharmaceuticals stock closing price was 207.84 on July 23, 2015.; The Alexion Pharmaceuticals 52-week high stock price is 162.60, which is 8.3% above the current share price. Other top laggards in the FTSE Nasdaq 100. Shares in Alexion Pharmaceuticals Inc (NSQ:ALXN) are currently trading at 109.82 but a key question for investors is how the economic uncertainty caused by Coronavirus will affect the price.